Logo image of DSFIR.AS

DSM-FIRMENICH AG (DSFIR.AS) Stock Fundamental Analysis

AMS:DSFIR - Euronext Amsterdam - CH1216478797 - Common Stock - Currency: EUR

82.38  -0.18 (-0.22%)

Fundamental Rating

4

DSFIR gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 68 industry peers in the Chemicals industry. The financial health of DSFIR is average, but there are quite some concerns on its profitability. DSFIR is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

3

1. Profitability

1.1 Basic Checks

DSFIR had positive earnings in the past year.
DSFIR had a positive operating cash flow in the past year.
DSFIR.AS Yearly Net Income VS EBIT VS OCF VS FCFDSFIR.AS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 2024 0 500M 1B 1.5B 2B

1.2 Ratios

DSFIR has a Return On Assets (0.74%) which is comparable to the rest of the industry.
DSFIR has a Return On Equity (1.11%) which is comparable to the rest of the industry.
DSFIR has a Return On Invested Capital (0.87%) which is comparable to the rest of the industry.
Industry RankSector Rank
ROA 0.74%
ROE 1.11%
ROIC 0.87%
ROA(3y)5.56%
ROA(5y)N/A
ROE(3y)8.73%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
DSFIR.AS Yearly ROA, ROE, ROICDSFIR.AS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 2024 0 5 10 15

1.3 Margins

DSFIR has a Profit Margin (3.83%) which is in line with its industry peers.
In the last couple of years the Profit Margin of DSFIR has declined.
DSFIR's Operating Margin of 5.95% is in line compared to the rest of the industry. DSFIR outperforms 54.41% of its industry peers.
In the last couple of years the Operating Margin of DSFIR has declined.
DSFIR has a Gross Margin of 65.10%. This is amongst the best in the industry. DSFIR outperforms 97.06% of its industry peers.
In the last couple of years the Gross Margin of DSFIR has declined.
Industry RankSector Rank
OM 5.95%
PM (TTM) 3.83%
GM 65.1%
OM growth 3Y-15.02%
OM growth 5YN/A
PM growth 3Y-36.48%
PM growth 5YN/A
GM growth 3Y-3.22%
GM growth 5YN/A
DSFIR.AS Yearly Profit, Operating, Gross MarginsDSFIR.AS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 2024 0 10 20 30

More info and screens

5

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), DSFIR is destroying value.
Compared to 1 year ago, DSFIR has about the same amount of shares outstanding.
The debt/assets ratio for DSFIR is higher compared to a year ago.
DSFIR.AS Yearly Shares OutstandingDSFIR.AS Yearly Shares OutstandingYearly Shares Outstanding 2022 2023 2024 50M 100M 150M 200M 250M
DSFIR.AS Yearly Total Debt VS Total AssetsDSFIR.AS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2022 2023 2024 10B 20B 30B

2.2 Solvency

An Altman-Z score of 2.00 indicates that DSFIR is not a great score, but indicates only limited risk for bankruptcy at the moment.
DSFIR has a Altman-Z score of 2.00. This is comparable to the rest of the industry: DSFIR outperforms 45.59% of its industry peers.
DSFIR has a debt to FCF ratio of 5.21. This is a neutral value as DSFIR would need 5.21 years to pay back of all of its debts.
DSFIR's Debt to FCF ratio of 5.21 is fine compared to the rest of the industry. DSFIR outperforms 72.06% of its industry peers.
A Debt/Equity ratio of 0.20 indicates that DSFIR is not too dependend on debt financing.
With a decent Debt to Equity ratio value of 0.20, DSFIR is doing good in the industry, outperforming 72.06% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.2
Debt/FCF 5.21
Altman-Z 2
ROIC/WACC0.19
WACC4.47%
DSFIR.AS Yearly LT Debt VS Equity VS FCFDSFIR.AS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2022 2023 2024 5B 10B 15B 20B

2.3 Liquidity

A Current Ratio of 2.02 indicates that DSFIR has no problem at all paying its short term obligations.
Looking at the Current ratio, with a value of 2.02, DSFIR is in the better half of the industry, outperforming 61.76% of the companies in the same industry.
A Quick Ratio of 1.26 indicates that DSFIR should not have too much problems paying its short term obligations.
DSFIR has a Quick ratio of 1.26. This is in the better half of the industry: DSFIR outperforms 63.24% of its industry peers.
Industry RankSector Rank
Current Ratio 2.02
Quick Ratio 1.26
DSFIR.AS Yearly Current Assets VS Current LiabilitesDSFIR.AS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2022 2023 2024 2B 4B 6B 8B

More info and screens

4

3. Growth

3.1 Past

DSFIR shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -89.70%.
The earnings per share for DSFIR have been decreasing by -45.42% on average. This is quite bad
The Revenue has grown by 20.44% in the past year. This is a very strong growth!
DSFIR shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 3.80% yearly.
EPS 1Y (TTM)-89.7%
EPS 3Y-45.42%
EPS 5YN/A
EPS Q2Q%N/A
Revenue 1Y (TTM)20.44%
Revenue growth 3Y3.8%
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

DSFIR is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 12.01% yearly.
DSFIR is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 3.63% yearly.
EPS Next Y33.33%
EPS Next 2Y19.8%
EPS Next 3Y17.29%
EPS Next 5Y12.01%
Revenue Next Year1.24%
Revenue Next 2Y2.09%
Revenue Next 3Y3.13%
Revenue Next 5Y3.63%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
DSFIR.AS Yearly Revenue VS EstimatesDSFIR.AS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 5B 10B 15B
DSFIR.AS Yearly EPS VS EstimatesDSFIR.AS Yearly EPS VS EstimatesYearly EPS VS Estimates 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2 4 6

More info and screens

3

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 87.64, DSFIR can be considered very expensive at the moment.
DSFIR's Price/Earnings is on the same level as the industry average.
DSFIR's Price/Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 26.48.
DSFIR is valuated rather expensively with a Price/Forward Earnings ratio of 19.02.
DSFIR's Price/Forward Earnings is on the same level as the industry average.
The average S&P500 Price/Forward Earnings ratio is at 34.04. DSFIR is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE 87.64
Fwd PE 19.02
DSFIR.AS Price Earnings VS Forward Price EarningsDSFIR.AS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80

4.2 Price Multiples

The rest of the industry has a similar Enterprise Value to EBITDA ratio as DSFIR.
Based on the Price/Free Cash Flow ratio, DSFIR is valued a bit cheaper than the industry average as 69.12% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 21.58
EV/EBITDA 13.45
DSFIR.AS Per share dataDSFIR.AS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60 80

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates DSFIR does not grow enough to justify the current Price/Earnings ratio.
DSFIR's earnings are expected to grow with 17.29% in the coming years. This may justify a more expensive valuation.
PEG (NY)2.63
PEG (5Y)N/A
EPS Next 2Y19.8%
EPS Next 3Y17.29%

More info and screens

3

5. Dividend

5.1 Amount

DSFIR has a Yearly Dividend Yield of 2.96%.
DSFIR's Dividend Yield is a higher than the industry average which is at 3.02.
Compared to an average S&P500 Dividend Yield of 2.40, DSFIR pays a bit more dividend than the S&P500 average.
Industry RankSector Rank
Dividend Yield 2.96%

5.2 History

Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
DSFIR.AS Yearly Dividends per shareDSFIR.AS Yearly Dividends per shareYearly Dividends per share 2024 2025 0.5 1 1.5 2

5.3 Sustainability

266.80% of the earnings are spent on dividend by DSFIR. This is not a sustainable payout ratio.
DP266.8%
EPS Next 2Y19.8%
EPS Next 3Y17.29%
DSFIR.AS Yearly Income VS Free CF VS DividendDSFIR.AS Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2021 2022 2023 2024 500M 1B 1.5B 2B
DSFIR.AS Dividend Payout.DSFIR.AS Dividend Payout, showing the Payout Ratio.DSFIR.AS Dividend Payout.PayoutRetained Earnings

More info and screens

DSM-FIRMENICH AG

AMS:DSFIR (8/8/2025, 7:00:00 PM)

82.38

-0.18 (-0.22%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)07-31 2025-07-31
Earnings (Next)10-30 2025-10-30
Inst Owners25.14%
Inst Owner ChangeN/A
Ins Owners9.64%
Ins Owner ChangeN/A
Market Cap21.89B
Analysts81.29
Price Target127.04 (54.21%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 2.96%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP266.8%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-0.48%
PT rev (3m)-2.42%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-1.4%
Revenue NY rev (3m)-2.57%
Valuation
Industry RankSector Rank
PE 87.64
Fwd PE 19.02
P/S 3.36
P/FCF 21.58
P/OCF 12.31
P/B 0.97
P/tB 4.94
EV/EBITDA 13.45
EPS(TTM)0.94
EY1.14%
EPS(NY)4.33
Fwd EY5.26%
FCF(TTM)3.82
FCFY4.63%
OCF(TTM)6.69
OCFY8.12%
SpS24.54
BVpS84.73
TBVpS16.69
PEG (NY)2.63
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 0.74%
ROE 1.11%
ROCE 1.32%
ROIC 0.87%
ROICexc 0.95%
ROICexgc 2.96%
OM 5.95%
PM (TTM) 3.83%
GM 65.1%
FCFM 15.55%
ROA(3y)5.56%
ROA(5y)N/A
ROE(3y)8.73%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-15.02%
OM growth 5YN/A
PM growth 3Y-36.48%
PM growth 5YN/A
GM growth 3Y-3.22%
GM growth 5YN/A
F-Score6
Asset Turnover0.19
Health
Industry RankSector Rank
Debt/Equity 0.2
Debt/FCF 5.21
Debt/EBITDA 2.44
Cap/Depr 53.43%
Cap/Sales 11.72%
Interest Coverage 5.79
Cash Conversion 97.8%
Profit Quality 405.6%
Current Ratio 2.02
Quick Ratio 1.26
Altman-Z 2
F-Score6
WACC4.47%
ROIC/WACC0.19
Cap/Depr(3y)68.18%
Cap/Depr(5y)N/A
Cap/Sales(3y)6.69%
Cap/Sales(5y)N/A
Profit Quality(3y)150.6%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-89.7%
EPS 3Y-45.42%
EPS 5YN/A
EPS Q2Q%N/A
EPS Next Y33.33%
EPS Next 2Y19.8%
EPS Next 3Y17.29%
EPS Next 5Y12.01%
Revenue 1Y (TTM)20.44%
Revenue growth 3Y3.8%
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next Year1.24%
Revenue Next 2Y2.09%
Revenue Next 3Y3.13%
Revenue Next 5Y3.63%
EBIT growth 1Y226.7%
EBIT growth 3Y-11.79%
EBIT growth 5YN/A
EBIT Next Year140.16%
EBIT Next 3Y38.54%
EBIT Next 5Y24.19%
FCF growth 1Y74.53%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y40.55%
OCF growth 3YN/A
OCF growth 5YN/A